Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,953,260
in 5 filings, $6.0M under 10b5-1 plans

Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$6.0M Chief Executive Officer sold 41% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-18 Madaus Martin D Director Grant or award · Stock Option (Right to Buy) +1,487 1,487
2023-05-18 Mhatre Rohin Director Grant or award +686 2,345
2023-05-18 Mhatre Rohin Director Grant or award · Stock Option (Right to Buy) +1,487 1,487
2023-05-18 DAWES KAREN A Director Grant or award +798 77,199
2023-05-18 DAWES KAREN A Director Grant or award · Stock Option (Right to Buy) +1,730 1,730
2023-05-18 EGLINTON MANNER CARRIE Director Grant or award +686 2,167
2023-05-18 EGLINTON MANNER CARRIE Director Grant or award · Stock Option (Right to Buy) +1,487 1,487
2023-05-18 BARTHELEMY NICOLAS Director Grant or award +686 2,767
2023-05-18 BARTHELEMY NICOLAS Director Grant or award · Stock Option (Right to Buy) +1,487 1,487
2023-05-18 MUIR GLENN P Director Grant or award +686 7,582
2023-05-18 MUIR GLENN P Director Grant or award · Stock Option (Right to Buy) +1,487 1,487
2023-05-18 Konstantinov Konstantin Director Grant or award +686 1,220
2023-05-18 Konstantinov Konstantin Director Grant or award · Stock Option (Right to Buy) +1,487 1,487
2023-05-16 KURIYEL RALF Senior VP, R&D Shares withheld for taxes −710 $154.03 $109K 23,556
2023-05-16 Gebski Christine See Remarks Shares withheld for taxes −334 $154.03 $51K 32,575
2023-05-16 Snodgres Jon Chief Financial Officer Shares withheld for taxes −710 $154.03 $109K 37,381
2023-05-08 Madaus Martin D Director Purchase +500 $156.18 $78K 1,611
2023-05-05 Madaus Martin D Director Purchase +500 $159.19 $80K 1,111
2023-05-04 Madaus Martin D Director Purchase +500 $161.15 $81K 611
2023-04-04 Bylund James Chief Operating Officer Shares withheld for taxes −334 $163.45 $55K 17,568

Page 15 of 23 · 455 trades